Search results
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters· 3 hours agoGlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of...
Pfizer (PFE) Rises Higher Than Market: Key Facts
Zacks via Yahoo Finance· 3 days agoPfizer (PFE) closed at $26.26 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily gain of 0.87%....
Pfizer Inc. (PFE) Becoming More Attractive for Investors – Knox Daily
Knox Daily· 3 days agoAs a result of the transaction, Gottlieb Scott now holds 5,000 shares, worth roughly $0.13 million. Argus downgraded its Pfizer Inc. [PFE] rating to a Hold from a a Buy in ...
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 22 hours agoIn December, Pfizer scrapped its twice-daily pill due to unexpectedly high rates of nausea and...
EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)
Seeking Alpha· 3 days agoEU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...
Pfizer (PFE) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 2 days agoPfizer (NYSE:PFE – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 1st. Pfizer has set its FY24 guidance at $2.05 ...
...Patent Battle over Covid-19 Vaccines In Legal Showdown - Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE...
Benzinga· 2 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Bristol-Myers stock falls despite Q1 beat (NYSE:BMY)
Seeking Alpha· 5 hours agoBristol-Myers Squibb (BMY) stock dips even as the company topped consensus with Q1 2024 results, despite headwinds in its growth portfolio. Read more...